The dual regulation of substance P-mediated inflammation via human synovial mast cells in rheumatoid arthritis

Allergology International

Volumn 66, Issue , 2017, Pages S9-S20

  Okamura, Yuki ^a   Mishima, Shintaro ^a   Kashiwakura, Jun ichi ^a,b   Sasaki Sakamoto, Tomomi ^a   Toyoshima, Shota ^a   Kuroda, Kazumichi ^a   Saito, Shu ^a   Tokuhashi, Yasuaki ^a   Okayama, Yoshimichi ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Mast cell; Osteoarthritis; Rheumatoid arthritis; Substance P; Synovium

Indexed keywords

CHYMASE; FC EPSILON RECEPTOR I; FC RECEPTOR; HISTAMINE; IMMUNOGLOBULIN G; LENTIVIRUS VECTOR; MASTER RELATED GENE X2; MESSENGER RNA; PROTEIN; SHORT HAIRPIN RNA; STEM CELL FACTOR; SUBSTANCE P; TACHYKININ; TACHYKININ 1; UNCLASSIFIED DRUG; AUTACOID; BIOLOGICAL MARKER; CYTOKINE;

ADULT; AGED; ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME IMMUNOASSAY; FEMALE; GENE EXPRESSION; GENE SILENCING; HISTAMINE RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; INFLAMMATION; MALE; MAST CELL; MIDDLE AGED; OSTEOARTHRITIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; SYNOVIUM; UPREGULATION; VERY ELDERLY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; BIOMARKERS; CELLS, CULTURED; CYTOKINES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; HUMANS; INFLAMMATION MEDIATORS; MALE; MAST CELLS; MIDDLE AGED; OSTEOARTHRITIS; RNA, MESSENGER; SUBSTANCE P; SYNOVIOCYTES;

EID: 85016483020     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.1016/j.alit.2017.03.002     Document Type: Article

References (45)

1. Furst, D.E., Emery, P., Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets. Rheumatology (Oxford) 53 (2014), 1560–1569.
2. Sarzi-Puttini, P., Salaffi, F., Di Franco, M., Bazzichi, L., Cassisi, G., Casale, R., et al. Pain in rheumatoid arthritis: a critical review. Reumatismo 66 (2014), 18–27.
3. Cazzola, M., Atzeni, F., Boccassini, L., Cassisi, G., Sarzi-Puttini, P., Physiopathology of pain in rheumatology. Reumatismo 66 (2014), 4–13.
4. Pennefather, J.N., Lecci, A., Candenas, M.L., Patak, E., Pinto, F.M., Maggi, C.A., Tachykinins and tachykinin receptors: a growing family. Life Sci 74 (2004), 1445–1463.
5. Lotz, M., Carson, D.A., Vaughan, J.H., Substance P activation of rheumatoid synoviocytes: neural pathway in pathogenesis of arthritis. Science 235 (1987), 893–895.
6. Lambert, N., Lescoulie, P.L., Yassine-Diab, B., Enault, G., Mazieres, B., De Preval, C., et al. Substance P enhances cytokine-induced vascular cell adhesion molecule-1 (VCAM-1) expression on cultured rheumatoid fibroblast-like synoviocytes. Clin Exp Immunol 113 (1998), 269–275.
7. Raap, T., Justen, H.P., Miller, L.E., Cutolo, M., Scholmerich, J., Straub, R.H., Neurotransmitter modulation of interleukin 6 (IL-6) and IL-8 secretion of synovial fibroblasts in patients with rheumatoid arthritis compared to osteoarthritis. J Rheumatol 27 (2000), 2558–2565.
8. Iwasaki, A., Inoue, K., Hukuda, S., Distribution of neuropeptide-containing nerve fibers in the synovium and adjacent bone of the rat knee joint. Clin Exp Rheumatol 13 (1995), 173–178.
9. Ahmed, M., Bjurholm, A., Schultzberg, M., Theodorsson, E., Kreicbergs, A., Increased levels of substance P and calcitonin gene-related peptide in rat adjuvant arthritis. A combined immunohistochemical and radioimmunoassay analysis. Arthritis Rheum 38 (1995), 699–709.
10. Levine, J.D., Clark, R., Devor, M., Helms, C., Moskowitz, M.A., Basbaum, A.I., Intraneuronal substance P contributes to the severity of experimental arthritis. Science 226 (1984), 547–549.
11. Seegers, H.C., Hood, V.C., Kidd, B.L., Cruwys, S.C., Walsh, D.A., Enhancement of angiogenesis by endogenous substance P release and neurokinin-1 receptors during neurogenic inflammation. J Pharmacol Exp Ther 306 (2003), 8–12.
12. Hong, S.K., Han, J.S., Min, S.S., Hwang, J.M., Kim, Y.I., Na, H.S., et al. Local neurokinin-1 receptor in the knee joint contributes to the induction, but not maintenance, of arthritic pain in the rat. Neurosci Lett 322 (2002), 21–24.
13. Lam, F.F., Ng, E.S., Substance P and glutamate receptor antagonists improve the anti-arthritic actions of dexamethasone in rats. Br J Pharmacol 159 (2010), 958–969.
14. Hernanz, A., De Miguel, E., Romera, N., Perez-Ayala, C., Gijon, J., Arnalich, F., Calcitonin gene-related peptide II, substance P and vasoactive intestinal peptide in plasma and synovial fluid from patients with inflammatory joint disease. Br J Rheumatol 32 (1993), 31–35.
15. Alstergren, P., Appelgren, A., Appelgren, B., Kopp, S., Lundeberg, T., Theodorsson, E., Co-variation of neuropeptide Y, calcitonin gene-related peptide, substance P and neurokinin A in joint fluid from patients with temporomandibular joint arthritis. Arch Oral Biol 40 (1995), 127–135.
16. Westermark, T., Rantapaa-Dahlqvist, S., Wallberg-Jonsson, S., Kjorell, U., Forsgren, S., Increased content of bombesin/GRP in human synovial fluid in early arthritis: different pattern compared with substance P. Clin Exp Rheumatol 19 (2001), 715–720.
17. Grimsholm, O., Rantapaa-Dahlqvist, S., Forsgren, S., Levels of gastrin-releasing peptide and substance P in synovial fluid and serum correlate with levels of cytokines in rheumatoid arthritis. Arthritis Res Ther 7 (2005), R416–R426.
18. Marabini, S., Matucci-Cerinic, M., Geppetti, P., Del Bianco, E., Marchesoni, A., Tosi, S., et al. Substance P and somatostatin levels in rheumatoid arthritis, osteoarthritis, and psoriatic arthritis synovial fluid. Ann N Y Acad Sci 632 (1991), 435–436.
19. Menkes, C.J., Renoux, M., Laoussadi, S., Mauborgne, A., Bruxelle, J., Cesselin, F., Substance P levels in the synovium and synovial fluid from patients with rheumatoid arthritis and osteoarthritis. J Rheumatol 20 (1993), 714–717.
20. Miller, L.E., Justen, H.P., Scholmerich, J., Straub, R.H., The loss of sympathetic nerve fibers in the synovial tissue of patients with rheumatoid arthritis is accompanied by increased norepinephrine release from synovial macrophages. FASEB J 14 (2000), 2097–2107.
21. Weidler, C., Holzer, C., Harbuz, M., Hofbauer, R., Angele, P., Scholmerich, J., et al. Low density of sympathetic nerve fibres and increased density of brain derived neurotrophic factor positive cells in RA synovium. Ann Rheum Dis 64 (2005), 13–20.
22. Dirmeier, M., Capellino, S., Schubert, T., Angele, P., Anders, S., Straub, R.H., Lower density of synovial nerve fibres positive for calcitonin gene-related peptide relative to substance P in rheumatoid arthritis but not in osteoarthritis. Rheumatology (Oxford) 47 (2008), 36–40.
23. Crisp, A.J., Chapman, C.M., Kirkham, S.E., Schiller, A.L., Krane, S.M., Articular mastocytosis in rheumatoid arthritis. Arthritis Rheum 27 (1984), 845–851.
24. Malone, D.G., Irani, A.M., Schwartz, L.B., Barrett, K.E., Metcalfe, D.D., Mast cell numbers and histamine levels in synovial fluids from patients with diverse arthritides. Arthritis Rheum 29 (1986), 956–963.
25. Tetlow, L.C., Woolley, D.E., Mast cells, cytokines, and metalloproteinases at the rheumatoid lesion: dual immunolocalisation studies. Ann Rheum Dis 54 (1995), 896–903.
26. Tetlow, L.C., Woolley, D.E., Distribution, activation and tryptase/chymase phenotype of mast cells in the rheumatoid lesion. Ann Rheum Dis 54 (1995), 549–555.
27. Eklund, K.K., Mast cells in the pathogenesis of rheumatic diseases and as potential targets for anti-rheumatic therapy. Immunol Rev 217 (2007), 38–52.
28. Nigrovic, P.A., Binstadt, B.A., Monach, P.A., Johnsen, A., Gurish, M., Iwakura, Y., et al. Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1. Proc Natl Acad Sci U S A 104 (2007), 2325–2330.
29. Lee, H.K.J., Matsuda, A., Watanabe, Y., Sakamoto-Sasaki, T., Matsumoto, K., Hashimoto, N., et al. Activation of human synovial mast cells from rheumatoid arthritis or osteoarthritis patients in response to aggregated IgG through FcγRI and FcγRII. Arthritis Rheum 65 (2013), 109–119.
30. Sumpter, T.L., Ho, C.H., Pleet, A.R., Tkacheva, O.A., Shufesky, W.J., Rojas-Canales, D.M., et al. Autocrine hemokinin-1 functions as an endogenous adjuvant for IgE-mediated mast cell inflammatory responses. J Allergy Clin Immunol 135 (2015), 1019–1030 e1018.
31. Tatemoto, K., Nozaki, Y., Tsuda, R., Konno, S., Tomura, K., Furuno, M., et al. Immunoglobulin E-independent activation of mast cell is mediated by Mrg receptors. Biochem Biophys Res Commun 349 (2006), 1322–1328.
32. Fujisawa, D., Kashiwakura, J., Kita, H., Kikukawa, Y., Fujitani, Y., Sasaki-Sakamoto, T., et al. Expression of Mas-related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticaria. J Allergy Clin Immunol 134 (2014), 622–633 e629.
33. Ho, W.Z., Lai, J.P., Zhu, X.H., Uvaydova, M., Douglas, S.D., Human monocytes and macrophages express substance P and neurokinin-1 receptor. J Immunol 159 (1997), 5654–5660.
34. Okayama, Y., Tkaczyk, C., Metcalfe, D.D., Gilfillan, A.M., Comparison of FcɛRI- and FcγRI-mediated degranulation and TNF-α synthesis in human mast cells: selective utilization of phosphatidylinositol-3-kinase for FcγRI-induced degranulation. Eur J Immunol 33 (2003), 1450–1459.
35. Caughey, G.H., Leidig, F., Viro, N.F., Nadel, J.A., Substance P and vasoactive intestinal peptide degradation by mast cell tryptase and chymase. J Pharmacol Exp Ther 244 (1988), 133–137.
36. He, S., Gaca, M.D., McEuen, A.R., Walls, A.F., Inhibitors of chymase as mast cell-stabilizing agents: contribution of chymase in the activation of human mast cells. J Pharmacol Exp Ther 291 (1999), 517–523.
37. Caughey, G.H., Viro, N.F., Ramachandran, J., Lazarus, S.C., Borson, D.B., Nadel, J.A., Dog mastocytoma tryptase: affinity purification, characterization, and amino-terminal sequence. Arch Biochem Biophys 258 (1987), 555–563.
38. Suurmond, J., Rivellese, F., Dorjee, A.L., Bakker, A.M., Rombouts, Y.J., Rispens, T., et al. Toll-like receptor triggering augments activation of human mast cells by anti-citrullinated protein antibodies. Ann Rheum Dis 74 (2015), 1915–1923.
39. Rivellese, F., Suurmond, J., Habets, K., Dorjee, A.L., Ramamoorthi, N., Townsend, M.J., et al. Human mast cells triggered with interleukin-33 and immune complexes down-regulate monocyte-mediated immune responses. Arthritis Rheumatol 67 (2015), 2343–2353.
40. Bromley, M., Woolley, D.E., Histopathology of the rheumatoid lesion. Identification of cell types at sites of cartilage erosion. Arthritis Rheum 27 (1984), 857–863.
41. Gibbs, B.F., Wierecky, J., Welker, P., Henz, B.M., Wolff, H.H., Grabbe, J., Human skin mast cells rapidly release preformed and newly generated TNF-α and IL-8 following stimulation with anti-IgE and other secretagogues. Exp Dermatol 10 (2001), 312–320.
42. Guhl, S., Lee, H.H., Babina, M., Henz, B.M., Zuberbier, T., Evidence for a restricted rather than generalized stimulatory response of skin-derived human mast cells to substance P. J Neuroimmunol 163 (2005), 92–101.
43. Kulka, M., Sheen, C.H., Tancowny, B.P., Grammer, L.C., Schleimer, R.P., Neuropeptides activate human mast cell degranulation and chemokine production. Immunology 123 (2008), 398–410.
44. Church, M.K., Okayama, Y., el-Lati, S., Mediator secretion from human skin mast cells provoked by immunological and non-immunological stimulation. Skin Pharmacol 4:Suppl 1 (1991), 15–24.
45. 2 receptor CRTH2 exacerbates adjuvant-induced joint inflammation. J Immunol 193 (2014), 5835–5840.